Q4 2019 Ultimovacs ASA Earnings Call Transcript
Good morning, and welcome to the fourth quarter presentation from Ultimovacs. My name is Jónas Einarsson, I'm the Chairman of the Board of Ultimovacs. And the reason why I'm standing here today is that you've probably all seen that we issued a press release yesterday, that we have appointed Carlos de Sousa as the new CEO of Ultimovacs, and he is beginning at this year June 1.
We're very pleased that Carlos has accepted to take over from Ãyvind Arnesen. Carlos has a very broad and long experience in working in both biotech companies and in big pharma. And you can read more about his background in the press release. We're also very pleased that Ãyvind is willing to sign up to be on the (Inaudible) post until the June 1, and he will absolutely be the CEO of Ultimovacs until that date.
So very pleased to say that we will not lose Ãyvind out of our system. He will move a couple of sales down from his office today on June 1, and start working together with my colleague, and this team, and myself in Ultimovacs as the consultant. So we
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |